In CML samples, there was no notable difference between BCR/ABL major (n = 8) and BCR/ABL minor samples (n = 3) in terms of MKRN2 or RAF1 mRNA expression (Fig C in File S1). The gene discussed is RAF1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.